The Trump Administration’s abrupt cancellation of National Institutes of Health meetings and grant reviews has sparked concerns that medical breakthroughs will be stalled and DEI initiatives shut down.

President Trump directed federal science agencies to cancel all scheduled meetings, effectively suspending NIH research grants.

A pause in communication is typical during a new administration’s transition. But some scientists fear that tying up NIH grant funding for any length of time could disrupt ongoing, time-sensitive clinical research.